Stock that is under sign of accumulationThe fundamentally strong stock that is showing signs of accumulation near key moving averages
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
15 SEK
172.20 M SEK
1.59 B SEK
11.35 M
About MEDCAP AB
Sector
Industry
CEO
Anders Dahlberg
Website
Headquarters
Stockholm
Founded
2001
ISIN
SE0009160872
FIGI
BBG000QRS5S9
MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. It operates through the MedTech and Specialty Pharma segments. The firm's portfolio includes: Abilia, Cardiolex Medical, Multi-ply, Inpac, and Unimedic. The company was founded in 2001 and is headquartered in Stockholm, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MCAP is 598 SEK — it has decreased by −0.83% in the past 24 hours. Watch MEDCAP AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange MEDCAP AB stocks are traded under the ticker MCAP.
MCAP stock has fallen by −0.83% compared to the previous week, the month change is a 8.78% rise, over the last year MEDCAP AB has showed a 74.34% increase.
We've gathered analysts' opinions on MEDCAP AB future price: according to them, MCAP price has a max estimate of 575.00 SEK and a min estimate of 535.00 SEK. Watch MCAP chart and read a more detailed MEDCAP AB stock forecast: see what analysts think of MEDCAP AB and suggest that you do with its stocks.
MCAP reached its all-time high on Jul 23, 2024 with the price of 624 SEK, and its all-time low was 5 SEK and was reached on Apr 1, 2009. View more price dynamics on MCAP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MCAP stock is 1.86% volatile and has beta coefficient of 0.93. Track MEDCAP AB stock price on the chart and check out the list of the most volatile stocks — is MEDCAP AB there?
Today MEDCAP AB has the market capitalization of 8.98 B, it has decreased by −1.99% over the last week.
Yes, you can track MEDCAP AB financials in yearly and quarterly reports right on TradingView.
MEDCAP AB is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
MCAP earnings for the last quarter are 2.90 SEK per share, whereas the estimation was 3.20 SEK resulting in a −9.38% surprise. The estimated earnings for the next quarter are 4.80 SEK per share. See more details about MEDCAP AB earnings.
MEDCAP AB revenue for the last quarter amounts to 413.10 M SEK, despite the estimated figure of 424.00 M SEK. In the next quarter, revenue is expected to reach 513.20 M SEK.
MCAP net income for the last quarter is 52.90 M SEK, while the quarter before that showed 56.80 M SEK of net income which accounts for −6.87% change. Track more MEDCAP AB financial stats to get the full picture.
No, MCAP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 514.00 employees. See our rating of the largest employees — is MEDCAP AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDCAP AB EBITDA is 381.70 M SEK, and current EBITDA margin is 19.60%. See more stats in MEDCAP AB financial statements.
Like other stocks, MCAP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDCAP AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDCAP AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDCAP AB stock shows the strong buy signal. See more of MEDCAP AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.